Nephrocare Health Services, known as NephroPlus, is set to file its DRHP with SEBI by the end of this month, aiming to raise over ₹2,000 crore through an IPO. The IPO will include a fresh issue and an offer for sale, with proceeds earmarked for expanding dialysis centers and acquiring mid-sized players in India and the Philippines.